• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿激酶氨基末端片段受体在体外建立的人表皮细胞系基质接触位点的选择性定位。

Selective localization of receptors for urokinase amino-terminal fragment at substratum contact sites of an in vitro-established line of human epidermal cells.

作者信息

Del Rosso M, Pedersen N, Fibbi G, Pucci M, Dini G, Anichini E, Blasi F

机构信息

Istituto di Patologia Generale, Università di Firenze, Italy.

出版信息

Exp Cell Res. 1992 Dec;203(2):427-34. doi: 10.1016/0014-4827(92)90017-3.

DOI:10.1016/0014-4827(92)90017-3
PMID:1333982
Abstract

We have shown the presence of surface receptors for the amino-terminal fragment (ATF) of human urokinase-type plasminogen activator (u-PA) on an in vitro-established cell line of human epidermal origin by both radio-binding assays with human 125I-u-PA-ATF and transmission electron microscopy of a gold-u-PA complex. On the basis of cross-linking experiments with 125I-u-PA-ATF and subsequent autoradiography of the gels we have observed that such receptors are not spontaneously released into the culture medium. The treatment with phosphatidylinositol-specific phospholipase C induces the release of the receptor, which behaves as a glycosyl phosphatidyl inositol(GPI)-anchored protein. Phase-partitioning experiments on cell lysates have shown that the receptor partitions into the detergent phase. By detaching cell monolayers with the chelating agent EDTA we have prepared the cell-substratum contact sites of these cells, which represent only the 3.5% of the surface membrane of monolayered cells. Such plasma membrane remnants are highly selected since they contain about 43% of total u-PA-ATF binding sites. Such binding sites show the same biochemical and morphological characteristics of u-PA-ATF receptors observed in the monolayered cells, thus indicating that u-PA is selectively concentrated at the level of cell-substratum contacts. This is likely to enable directional proteolysis for cell migration and invasion.

摘要

我们通过用人125I - u - PA - ATF进行放射结合测定以及对金 - u - PA复合物进行透射电子显微镜观察,已证实在一种体外建立的人表皮源细胞系上存在人尿激酶型纤溶酶原激活剂(u - PA)氨基末端片段(ATF)的表面受体。基于用125I - u - PA - ATF进行的交联实验以及随后对凝胶的放射自显影,我们观察到此类受体不会自发释放到培养基中。用磷脂酰肌醇特异性磷脂酶C处理可诱导受体释放,该受体表现为糖基磷脂酰肌醇(GPI)锚定蛋白。对细胞裂解物进行相分配实验表明,该受体分配到去污剂相中。通过用螯合剂EDTA分离细胞单层,我们制备了这些细胞的细胞 - 基质接触位点,其仅占单层细胞表面膜的3.5%。这种质膜残余物经过高度筛选,因为它们含有约43%的总u - PA - ATF结合位点。此类结合位点显示出与在单层细胞中观察到的u - PA - ATF受体相同的生化和形态特征,从而表明u - PA在细胞 - 基质接触水平上被选择性富集。这可能有助于细胞迁移和侵袭的定向蛋白水解。

相似文献

1
Selective localization of receptors for urokinase amino-terminal fragment at substratum contact sites of an in vitro-established line of human epidermal cells.尿激酶氨基末端片段受体在体外建立的人表皮细胞系基质接触位点的选择性定位。
Exp Cell Res. 1992 Dec;203(2):427-34. doi: 10.1016/0014-4827(92)90017-3.
2
Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol.
J Biol Chem. 1991 Jan 25;266(3):1926-33.
3
Localization of urokinase-type plasminogen activator receptor on U937 cells: phorbol ester PMA induces heterogeneity.
Exp Cell Res. 1990 Apr;187(2):255-62. doi: 10.1016/0014-4827(90)90089-s.
4
Demonstration of a specific clearance receptor for tissue-type plasminogen activator on rat Novikoff hepatoma cells.
J Biol Chem. 1992 Mar 25;267(9):6249-56.
5
Two-chain urokinase, receptor, and type 1 inhibitor in cultured human mesangial cells.培养的人肾小球系膜细胞中的双链尿激酶、受体和1型抑制剂。
Am J Physiol. 1993 Mar;264(3 Pt 2):F532-9. doi: 10.1152/ajprenal.1993.264.3.F532.
6
Production of second messengers following chemotactic and mitogenic urokinase-receptor interaction in human fibroblasts and mouse fibroblasts transfected with human urokinase receptor.人成纤维细胞和转染人尿激酶受体的小鼠成纤维细胞中,趋化性和促有丝分裂性尿激酶受体相互作用后第二信使的产生。
Exp Cell Res. 1994 Aug;213(2):438-48. doi: 10.1006/excr.1994.1221.
7
Proteolytically active streptococcal pyrogenic exotoxin B cleaves monocytic cell urokinase receptor and releases an active fragment of the receptor from the cell surface.
J Biol Chem. 1994 Dec 2;269(48):30682-7.
8
Urokinase-urokinase receptor interaction: non-mitogenic signal transduction in human epidermal cells.尿激酶-尿激酶受体相互作用:人表皮细胞中的非促有丝分裂信号转导
Biochem Biophys Res Commun. 1993 Jan 29;190(2):347-52. doi: 10.1006/bbrc.1993.1054.
9
Urokinase-type plasminogen activator-induced monocyte adhesion requires a carboxyl-terminal lysine and cAMP-dependent signal transduction.
J Biol Chem. 1995 Dec 22;270(51):30282-5. doi: 10.1074/jbc.270.51.30282.
10
Soluble urokinase receptor from fibrosarcoma HT-1080 cells.
Blood Coagul Fibrinolysis. 1994 Aug;5(4):473-8.

引用本文的文献

1
Raloxifene reduces urokinase-type plasminogen activator-dependent proliferation of synoviocytes from patients with rheumatoid arthritis.雷洛昔芬可降低类风湿关节炎患者滑膜细胞中尿激酶型纤溶酶原激活物依赖性增殖。
Arthritis Res Ther. 2005;7(6):R1244-53. doi: 10.1186/ar1815. Epub 2005 Sep 8.
2
Role of urokinase and its receptor in basal and stimulated colonic epithelial cell migration in vitro.尿激酶及其受体在体外基础状态和刺激状态下结肠上皮细胞迁移中的作用。
Gut. 2000 Jul;47(1):105-11. doi: 10.1136/gut.47.1.105.